http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201733596-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_509dcdee307c173971b32910685d906e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate | 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d19867c753285727a94c092ae2b7ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34066654788cb2b0fd702dd364db117d |
| publicationDate | 2017-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201733596-A |
| titleOfInvention | Uridine glycosides prodrug, preparation method thereof and pharmaceutical composition thereof |
| abstract | The present invention relates to a uridine-based phosphonamine prodrug, a preparation method thereof and its use in medicine, and the prodrug of the present invention is a compound represented by the formula I or an optical isomer thereof or a pharmaceutically thereof thereof An acceptable salt, the prodrug of the present invention further comprises a solvate of a compound of the formula I or an optical isomer thereof or a pharmaceutically acceptable salt thereof, the prodrug of the present invention can be treated Viral infectious diseases, especially C-hepatitis virus infectious diseases. □ |
| priorityDate | 2016-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.